Maintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset

Gelijkaardige items

• Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
  door: Ravelli, A, et al.
  Gepubliceerd in: (2014)
• Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis
  door: Quartier, P, et al.
  Gepubliceerd in: (2014)
• Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data
  door: Ruperto, N, et al.
  Gepubliceerd in: (2014)
• PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients
  door: Quartier, P, et al.
  Gepubliceerd in: (2013)
• Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
  door: Wulffraat, NM, et al.
  Gepubliceerd in: (2014)